Euformatics offers a comprehensive software platform designed for clinical genomic data analysis, facilitating the transition from raw next-generation sequencing (NGS) data to actionable clinical reports. Their Genomics Hub serves as a kit-agnostic data processing platform, allowing users to analyze genomic data from various sources. The platform is modular, enabling customization of features based on specific user needs, and can be deployed locally or in the cloud. Key functionalities include gene test validation, sample quality control, and variant interpretation, which collectively enhance the efficiency and accuracy of genomic analyses.

The company emphasizes the importance of high-quality data in ensuring patient safety and regulatory compliance. Their solutions support laboratories in measuring and documenting data quality according to established guidelines, such as IVDR and EuroGentest. By automating processes and minimizing human error, Euformatics aims to improve operational efficiency in genomic testing. Their commitment to advancing precision medicine is reflected in their partnerships with leading organizations and their focus on providing tools that empower clinicians to leverage genomic data effectively for better patient care.

Finland

Euformatics provides expert computational services at the intersection of life sciences and software.

Our mission is to bridge the gap between practicing life scientists and creators of new data analysis and modeling methods, accelerating the transition to precision medicine. Our focus is in adapting cutting-edge research in computational methods and putting them to practice.

Our customers are biotech companies and healthcare providers in Finland and abroad.

Euformatics

Company Details